APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Opioid Patch

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-Opioid Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchNon-Opioid Patch Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Opioid Patch Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Non-Opioid Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Opioid Patch Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Opioid Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non-Opioid Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Opioid Patch include Teva Pharmaceutical Industries Ltd, Johnson and Johnson, Viatris Inc., Sorrento Therapeutics Inc., Purdue Pharma L.P., NEXGEL Advanced Hydrogel Solutions, Hisamitsu Pharmaceutical Co.,Inc., Grunenthal and Endo International plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Opioid Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Opioid Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Opioid Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Opioid Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Opioid Patch Segment by Company

Teva Pharmaceutical Industries Ltd

Johnson and Johnson

Viatris Inc.

Sorrento Therapeutics Inc.

Purdue Pharma L.P.

NEXGEL Advanced Hydrogel Solutions

Hisamitsu Pharmaceutical Co.,Inc.

Grunenthal

Endo International plc.

Amneal Pharmaceuticals LLC

Non-Opioid Patch Segment by Type

Prescription Medicines

OTC Medicines

Non-Opioid Patch Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Non-Opioid Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Opioid Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Opioid Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Opioid Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Opioid Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-Opioid Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-Opioid Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-Opioid Patch Industry Trends Table 2. Non-Opioid Patch Industry Drivers Table 3. Non-Opioid Patch Industry Opportunities and Challenges Table 4. Non-Opioid Patch Industry Restraints Table 5. Global Non-Opioid Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-Opioid Patch Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-Opioid Patch Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Non-Opioid Patch Sales Market Share by Manufacturers Table 9. Global Non-Opioid Patch Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Non-Opioid Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-Opioid Patch Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-Opioid Patch Manufacturers, Product Type & Application Table 13. Global Non-Opioid Patch Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Opioid Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prescription Medicines Table 17. Major Manufacturers of OTC Medicines Table 18. Global Non-Opioid Patch Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Non-Opioid Patch Sales by Type (2021-2026) & (k units) Table 20. Global Non-Opioid Patch Sales by Type (2027-2032) & (k units) Table 21. Global Non-Opioid Patch Sales Market Share by Type (2021-2026) Table 22. Global Non-Opioid Patch Sales Market Share by Type (2027-2032) Table 23. Global Non-Opioid Patch Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Non-Opioid Patch Revenue by Type (2021-2026) & (k units) Table 25. Global Non-Opioid Patch Revenue by Type (2027-2032) & (k units) Table 26. Global Non-Opioid Patch Revenue Market Share by Type (2021-2026) Table 27. Global Non-Opioid Patch Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Pharmacies Table 29. Major Manufacturers of Drug Stores Table 30. Major Manufacturers of Online Pharmacies Table 31. Global Non-Opioid Patch Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Non-Opioid Patch Sales by Application (2021-2026) & (k units) Table 33. Global Non-Opioid Patch Sales by Application (2027-2032) & (k units) Table 34. Global Non-Opioid Patch Sales Market Share by Application (2021-2026) Table 35. Global Non-Opioid Patch Sales Market Share by Application (2027-2032) Table 36. Global Non-Opioid Patch Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Non-Opioid Patch Revenue by Application (2021-2026) & (k units) Table 38. Global Non-Opioid Patch Revenue by Application (2027-2032) & (k units) Table 39. Global Non-Opioid Patch Revenue Market Share by Application (2021-2026) Table 40. Global Non-Opioid Patch Revenue Market Share by Application (2027-2032) Table 41. Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Non-Opioid Patch Sales by Region (2021-2026) & (k units) Table 43. Global Non-Opioid Patch Sales Market Share by Region (2021-2026) Table 44. Global Non-Opioid Patch Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Non-Opioid Patch Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 48. North America Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 49. Europe Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 51. Europe Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 58. Global Non-Opioid Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Non-Opioid Patch Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Non-Opioid Patch Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Non-Opioid Patch Revenue Market Share by Region (2021-2026) Table 62. Global Non-Opioid Patch Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical Industries Ltd Company Information Table 64. Teva Pharmaceutical Industries Ltd Business Overview Table 65. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio Table 67. Teva Pharmaceutical Industries Ltd Recent Development Table 68. Johnson and Johnson Company Information Table 69. Johnson and Johnson Business Overview Table 70. Johnson and Johnson Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson and Johnson Non-Opioid Patch Product Portfolio Table 72. Johnson and Johnson Recent Development Table 73. Viatris Inc. Company Information Table 74. Viatris Inc. Business Overview Table 75. Viatris Inc. Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Viatris Inc. Non-Opioid Patch Product Portfolio Table 77. Viatris Inc. Recent Development Table 78. Sorrento Therapeutics Inc. Company Information Table 79. Sorrento Therapeutics Inc. Business Overview Table 80. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio Table 82. Sorrento Therapeutics Inc. Recent Development Table 83. Purdue Pharma L.P. Company Information Table 84. Purdue Pharma L.P. Business Overview Table 85. Purdue Pharma L.P. Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Purdue Pharma L.P. Non-Opioid Patch Product Portfolio Table 87. Purdue Pharma L.P. Recent Development Table 88. NEXGEL Advanced Hydrogel Solutions Company Information Table 89. NEXGEL Advanced Hydrogel Solutions Business Overview Table 90. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio Table 92. NEXGEL Advanced Hydrogel Solutions Recent Development Table 93. Hisamitsu Pharmaceutical Co.,Inc. Company Information Table 94. Hisamitsu Pharmaceutical Co.,Inc. Business Overview Table 95. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio Table 97. Hisamitsu Pharmaceutical Co.,Inc. Recent Development Table 98. Grunenthal Company Information Table 99. Grunenthal Business Overview Table 100. Grunenthal Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Grunenthal Non-Opioid Patch Product Portfolio Table 102. Grunenthal Recent Development Table 103. Endo International plc. Company Information Table 104. Endo International plc. Business Overview Table 105. Endo International plc. Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Endo International plc. Non-Opioid Patch Product Portfolio Table 107. Endo International plc. Recent Development Table 108. Amneal Pharmaceuticals LLC Company Information Table 109. Amneal Pharmaceuticals LLC Business Overview Table 110. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio Table 112. Amneal Pharmaceuticals LLC Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Non-Opioid Patch Distributors List Table 116. Non-Opioid Patch Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Non-Opioid Patch Product Image Figure 2. Global Non-Opioid Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Opioid Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Opioid Patch Sales (2021-2032) & (k units) Figure 5. Global Non-Opioid Patch Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-Opioid Patch Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prescription Medicines Image Figure 9. OTC Medicines Image Figure 10. Global Non-Opioid Patch Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Non-Opioid Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Non-Opioid Patch Sales Market Share by Type (2021-2032) Figure 13. Global Non-Opioid Patch Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Non-Opioid Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Non-Opioid Patch Revenue Market Share by Type (2021-2032) Figure 16. Hospital Pharmacies Image Figure 17. Drug Stores Image Figure 18. Online Pharmacies Image Figure 19. Global Non-Opioid Patch Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Non-Opioid Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Non-Opioid Patch Sales Market Share by Application (2021-2032) Figure 22. Global Non-Opioid Patch Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Non-Opioid Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Non-Opioid Patch Revenue Market Share by Application (2021-2032) Figure 25. North America Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Non-Opioid Patch Sales Market Share by Country (2021-2032) Figure 27. U.S. Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Non-Opioid Patch Sales Market Share by Country (2021-2032) Figure 32. Germany Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Non-Opioid Patch Sales Market Share by Country (2021-2032) Figure 39. China Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Non-Opioid Patch Sales Market Share by Country (2021-2032) Figure 47. Brazil Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Non-Opioid Patch Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Non-Opioid Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Non-Opioid Patch Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Figure 58. North America Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Figure 60. Europe Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Non-Opioid Patch Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Non-Opioid Patch Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Non-Opioid Patch Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Medicines
  • OTC Medicines
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Johnson and Johnson
  • Viatris Inc.
  • Sorrento Therapeutics Inc.
  • Purdue Pharma L.P.
  • NEXGEL Advanced Hydrogel Solutions
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Grunenthal
  • Endo International plc.
  • Amneal Pharmaceuticals LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Opioid Patch Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Opioid Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-Opioid Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-Opioid Patch Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-Opioid Patch Market Dynamics
  1. 2.1 Non-Opioid Patch Industry Trends
  2. 2.2 Non-Opioid Patch Industry Drivers
  3. 2.3 Non-Opioid Patch Industry Opportunities and Challenges
  4. 2.4 Non-Opioid Patch Industry Restraints
3 Non-Opioid Patch Market by Manufacturers
  1. 3.1 Global Non-Opioid Patch Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-Opioid Patch Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-Opioid Patch Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-Opioid Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Opioid Patch Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-Opioid Patch Manufacturers, Product Type & Application
  7. 3.7 Global Non-Opioid Patch Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Opioid Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Opioid Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Opioid Patch Tier 1, Tier 2, and Tier 3
4 Non-Opioid Patch Market by Type
  1. 4.1 Non-Opioid Patch Type Introduction
  2. 4.1.1 Prescription Medicines
  3. 4.1.2 OTC Medicines
  4. 4.2 Global Non-Opioid Patch Sales by Type
  5. 4.2.1 Global Non-Opioid Patch Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-Opioid Patch Sales by Type (2021-2032)
  7. 4.2.3 Global Non-Opioid Patch Sales Market Share by Type (2021-2032)
  8. 4.3 Global Non-Opioid Patch Revenue by Type
  9. 4.3.1 Global Non-Opioid Patch Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-Opioid Patch Revenue by Type (2021-2032)
  11. 4.3.3 Global Non-Opioid Patch Revenue Market Share by Type (2021-2032)
5 Non-Opioid Patch Market by Application
  1. 5.1 Non-Opioid Patch Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Non-Opioid Patch Sales by Application
  6. 5.2.1 Global Non-Opioid Patch Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Opioid Patch Sales by Application (2021-2032)
  8. 5.2.3 Global Non-Opioid Patch Sales Market Share by Application (2021-2032)
  9. 5.3 Global Non-Opioid Patch Revenue by Application
  10. 5.3.1 Global Non-Opioid Patch Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-Opioid Patch Revenue by Application (2021-2032)
  12. 5.3.3 Global Non-Opioid Patch Revenue Market Share by Application (2021-2032)
6 Global Non-Opioid Patch Sales by Region
  1. 6.1 Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Opioid Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Opioid Patch Sales by Region (2021-2026)
  4. 6.2.2 Global Non-Opioid Patch Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-Opioid Patch Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-Opioid Patch Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-Opioid Patch Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-Opioid Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-Opioid Patch Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-Opioid Patch Revenue by Region
  1. 7.1 Global Non-Opioid Patch Revenue by Region
  2. 7.1.1 Global Non-Opioid Patch Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-Opioid Patch Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-Opioid Patch Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-Opioid Patch Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-Opioid Patch Revenue (2021-2032)
  8. 7.2.2 North America Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-Opioid Patch Revenue (2021-2032)
  11. 7.3.2 Europe Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-Opioid Patch Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-Opioid Patch Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-Opioid Patch Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd
  2. 8.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 8.2 Johnson and Johnson
  8. 8.2.1 Johnson and Johnson Company Information
  9. 8.2.2 Johnson and Johnson Business Overview
  10. 8.2.3 Johnson and Johnson Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
  12. 8.2.5 Johnson and Johnson Recent Developments
  13. 8.3 Viatris Inc.
  14. 8.3.1 Viatris Inc. Company Information
  15. 8.3.2 Viatris Inc. Business Overview
  16. 8.3.3 Viatris Inc. Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Viatris Inc. Non-Opioid Patch Product Portfolio
  18. 8.3.5 Viatris Inc. Recent Developments
  19. 8.4 Sorrento Therapeutics Inc.
  20. 8.4.1 Sorrento Therapeutics Inc. Company Information
  21. 8.4.2 Sorrento Therapeutics Inc. Business Overview
  22. 8.4.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
  24. 8.4.5 Sorrento Therapeutics Inc. Recent Developments
  25. 8.5 Purdue Pharma L.P.
  26. 8.5.1 Purdue Pharma L.P. Company Information
  27. 8.5.2 Purdue Pharma L.P. Business Overview
  28. 8.5.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
  30. 8.5.5 Purdue Pharma L.P. Recent Developments
  31. 8.6 NEXGEL Advanced Hydrogel Solutions
  32. 8.6.1 NEXGEL Advanced Hydrogel Solutions Company Information
  33. 8.6.2 NEXGEL Advanced Hydrogel Solutions Business Overview
  34. 8.6.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
  36. 8.6.5 NEXGEL Advanced Hydrogel Solutions Recent Developments
  37. 8.7 Hisamitsu Pharmaceutical Co.,Inc.
  38. 8.7.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
  39. 8.7.2 Hisamitsu Pharmaceutical Co.,Inc. Business Overview
  40. 8.7.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
  42. 8.7.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments
  43. 8.8 Grunenthal
  44. 8.8.1 Grunenthal Company Information
  45. 8.8.2 Grunenthal Business Overview
  46. 8.8.3 Grunenthal Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Grunenthal Non-Opioid Patch Product Portfolio
  48. 8.8.5 Grunenthal Recent Developments
  49. 8.9 Endo International plc.
  50. 8.9.1 Endo International plc. Company Information
  51. 8.9.2 Endo International plc. Business Overview
  52. 8.9.3 Endo International plc. Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Endo International plc. Non-Opioid Patch Product Portfolio
  54. 8.9.5 Endo International plc. Recent Developments
  55. 8.10 Amneal Pharmaceuticals LLC
  56. 8.10.1 Amneal Pharmaceuticals LLC Company Information
  57. 8.10.2 Amneal Pharmaceuticals LLC Business Overview
  58. 8.10.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
  60. 8.10.5 Amneal Pharmaceuticals LLC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Opioid Patch Value Chain Analysis
  2. 9.1.1 Non-Opioid Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Opioid Patch Production Mode & Process
  6. 9.2 Non-Opioid Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Opioid Patch Distributors
  9. 9.2.3 Non-Opioid Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst